Goldman Sachs (NYSE:GS) added UnitedHealth Group (NYSE:UNH) stock to its U.S. Conviction List, reiterating a Buy rating with a $435 price target. The firm argues UnitedHealth is nearing the bottom of its underwriting cycle in Medicare Advantage (MA), which represents 40% of its business. The Conviction List is reserved for Goldman’s highest-conviction Buy ideas. UnitedHealth ... Goldman Sachs Adds UnitedHealth to Its Conviction List: Is the Managed Care Comeback Real?
AI commentary is generated from public news feeds and is not investment advice.